-
Mashup Score: 13William Antonio Rivas - 4 year(s) ago
Very interesting case today! DX?
Source: www.facebook.comCategories: CardiologistsTweet
-
Mashup Score: 0
An abstract is unavailable.
Source: LWWCategories: Hem/Onc News and JournalsTweet-
Increasing Effectiveness of Chemo for Metastatic Colorectal Cancer https://t.co/lz2wOG79lt #Bestof2019 #health #medtwitter via @vallhebron https://t.co/BwwxGp1jNK
-
-
Mashup Score: 0Beeper Skipping - 4 year(s) ago
Retiring MD launches pager into the Susquehanna River.
Source: YouTubeCategories: CardiologistsTweet-
Physician burnout therapy: Throwing my beeper in the Susquehanna River 2011 after my last EP case. https://t.co/zQFewLYjzS via @YouTube #epeeps @gabrieldane
-
-
Mashup Score: 0Scalp EEG predicts temporal lobe resection success - 4 year(s) ago
BALTIMORE – There was one hundred percent failure if seizures spread within 10 seconds.
Source: www.mdedge.comCategories: General Medicine NewsTweet-
AMTR works in the majority of patients with refractory temporal lobe epilepsy, but up to 20% still have seizures. Yale University wanted to find a way to identify patients likely to fail surgery beforehand to help counsel them on what to expect. https://t.co/O17WNztkTc (AES 2019) https://t.co/T4dwfxfC8v
-
-
Mashup Score: 1Frontline Nivolumab Combo Succeeds in Squamous NSCLC, But Misses OS Endpoint in Nonsquamous Histology - 4 year(s) ago
The first-line combination of nivolumab and platinum-based chemotherapy improved overall survival, progression-free survival, and objective response rate compared with chemotherapy in patients with squamous non–small cell lung cancer, but did not improve survival in those with nonsquamous disease.
Source: OncLiveCategories: Hem/Onc News and JournalsTweet-
The first-line combination of nivolumab and platinum-based chemotherapy improved OS, PFS, and ORR compared with chemotherapy in patients with squamous NSCLC, but did not improve survival in those with nonsquamous disease #lcam #lcsm https://t.co/iXOkbmimZQ
-
-
Mashup Score: 4Heartbreaking News, Then Tumor Find Leads to Genetic Testing - 4 year(s) ago
The NCCN has updated guidelines for genetic testing for breast, ovarian, and pancreatic cancer, with a new list of high- to moderate-penetrance genes and a new section on pancreatic cancer.
Source: MedscapeCategories: General Medicine NewsTweet-
A heartbreaking health find turned lifesaving. https://t.co/ydeer2cvKf
-
-
Mashup Score: 0The US is sending roughly 100 more Marines to defend the embassy in Baghdad after violent protesters stormed the gate - 4 year(s) ago
The violent protests followed US airstrikes on Iran-backed militias in Iraq — strikes in retaliation for a rocket attack that killed a US citizen.
Source: Business InsiderCategories: Future of MedicineTweet-
US sending in Marines after violent protests at embassy in Baghdad - Business Insider https://t.co/U1uSe7QaAC
-
-
Mashup Score: 0
A simple change model, reliably implemented, has led to substantive change in the management of complex, intractable health care problems at one of the largest U.S. health systems.
Source: catalyst.nejm.orgCategories: CardiologistsTweet-
Nice model for implementing change at PSJH https://t.co/WycTBdYcF0 @BJC_HealthCare @WUSTLmed @amyleecp3 @nejmcatalyst #healthcareinnovationlab https://t.co/2gJhJ0y9Bn
-
-
Mashup Score: 0
In an interview with Targeted Oncology, Bianca D. Santomasso, MD, PhD, discussed the challenges with treating patients who develop neurotoxicity following treatment with new CAR T cells following her talk at the 2019 SOHO Annual Meeting. She also highlighted how the CAR T cells are changing the treatment landscape for patients with lymphomas.
Source: Targeted OncologyCategories: Hem/Onc News and JournalsTweet-
Experts addressed the role of CAR T-cell therapy in patients with hematologic malignancies, including lymphomas at the #SOHO19 meeting. https://t.co/goo6iRYwUH #cartcells
-
-
Mashup Score: 1Current Opinion - Wolters Kluwer - 4 year(s) ago
Contribute a better translation
Source: shop.lww.comCategories: Hem/Onc News and JournalsTweet-
Get insightful editorials and on-the-mark invited reviews covering key subjects in your field. Get your Lippincott Current Opinion Journals at 40% off today! https://t.co/M56b8DRkiC #tiptuesday #healthcare #MedTwitter https://t.co/WfPPWVZwXK
-
RT @fazalabul: Apical HCM or not https://t.co/16gI21ToxL https://t.co/szxWjNPoOR